Drug Shortage Report for LOVASTATIN

Last updated on 2021-01-13 History
Report ID 103759
Drug Identification Number 02353237
Brand name LOVASTATIN
Common or Proper name LOVASTATIN
Company Name SANIS HEALTH INC
Market Status MARKETED
Active Ingredient(s) LOVASTATIN
Strength(s) 40MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100
ATC code C10AA
ATC description LIPID MODIFYING AGENTS, PLAIN
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2021-01-12
Actual start date
Estimated end date Unknown
Actual end date
Shortage status Actual shortage
Updated date 2021-01-13
Company comments
Health Canada comments
Contact Address 1 PRESIDENTS CHOICE CIRCLE
BRAMPTON, ONTARIO
CANADA L6Y 5S5
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v3 2021-01-13 English Compare
v2 2020-01-21 French Compare
v1 2020-01-21 English Compare